View in EDS PDF Full Text

Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3.

Saved in:
Bibliographic Details
Title: Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)-N-(3,3,3-[18F]trifluoropropyl)acetamide, [18F]EF3.
Authors: Mahy, P.1, de Bast, M.1, Leveque, P. H.2,3, Gillart, J.2, Labar, D.2, Marchand, J.4, Gregoire, V.1 gregoire@rbnt.ucl.ac.be
Source: European Journal of Nuclear Medicine & Molecular Imaging. 2004, Vol. 31 Issue 9, p1263-1272. 10p.
Database: Academic Search Ultimate
Description
ISSN:16197070
DOI:10.1007/s00259-004-1573-2